tiprankstipranks
Evgen Pharma PLC (GB:TCF)
LSE:TCF
UK Market
TCF
Evgen Pharma
RESEARCH TOOLSreports
Want to see GB:TCF full AI Analyst Report?

Evgen Pharma (TCF) Stock News & Sentiment

5 Followers
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
Premium
Company Announcements
TheraCryf to Host Investor Webinar as Lead Addiction Drug Nears Clinical Stage
17d ago
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
Premium
Company Announcements
TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
18d ago
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
Premium
Company Announcements
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
22d ago
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
Premium
Company Announcements
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
24d ago
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
Premium
Company Announcements
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
2M ago
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
Premium
Company Announcements
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
3M ago
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
Premium
Company Announcements
TheraCryf Hits Key Manufacturing Milestone for Ox-1 Addiction Candidate
4M ago
More GB:TCF News >

TCF News on the Web

TheraCryf Hits Key Manufacturing Milestone for Lead Addiction Drug Ox-1
TipRanks News
Neutral
TheraCryf Files New Process Patent to Extend Exclusivity for Lead Addiction Drug
TipRanks News
Neutral
TheraCryf shares rise 23% after biotech rejects takeover approach for neuropsychiatry assets
Proactive Investors
Bullish
TheraCryf Rejects Bid for Lead Neuropsychiatry Assets, Backs In-House Growth Strategy
TipRanks News
Neutral
TheraCryf Advances Lead Addiction Drug to Final Preclinical Toxicology Milestone
TipRanks News
Neutral
TheraCryf Secures Final Major Ox‑1 Patent and Advances Addiction Drug Towards Clinical Stage
TipRanks News
Neutral
TheraCryf Director Increases Stake, Signaling Confidence in Strategic Direction
TipRanks News
Neutral
TheraCryf Plc Announces Major Voting Rights Transfer
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GB:TCF
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:TCF’s Media Buzz Sentiment?
4 articles about GB:TCF were published this week. In an average week, 0.25 articles are published.
    What is GB:TCF’s weekly average amount of articles?
    In an average week, 0.25 articles about GB:TCF are published.
      What is GB:TCF’s News Sentiment?
      100% of articles about GB:TCF were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week